Microgen
Information Management Solutions
4 October 2004
MICROGEN PLC APPOINTS NON EXECUTIVE DIRECTOR
With immediate effect, Mr Richard Holway is to be appointed a non-executive
Director of Microgen plc. The Microgen Board of Directors will now comprise 3
executive directors and 4 non-executive directors. Mr Holway will also join the
Board's Audit, Remuneration and Nominations Committees.
Mr Holway (57) started in computing in 1966 as a programmer, joined Hoskyns
(now Capgemini ) in 1968 and progressed to join the board in 1979 as Group
Marketing Director. In 1984, Richard was appointed Managing Director of Wootton
Jeffreys before forming Richard Holway Limited in 1986.
Richard Holway Limited became the leading commentator on the UK software and IT
services market and its constituent companies. In November 2000 Richard Holway
Limited was acquired by Ovum. Mr Holway serves on the Ovum board as a
non-executive director where he continues his role as an analyst in the IT
sector.
There are no further details required to be disclosed pursuant to paragraphs
6.F.2 (b) to (g) or 16.4 (a) of the UK Listing Authority Listing Rules.
For further information, please contact :
Microgen plc Tel : 01753-847123
Martyn Ratcliffe - Executive Chairman
Richard Holway Tel : 01252-781545
Financial Dynamics
Giles Sanderson / Ben Way Tel: 020 7831 3113
www.microgen.co.uk
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.